Joanna Haas

Summary

Affiliation: Genzyme Corporation
Country: USA

Publications

  1. ncbi A problem-oriented approach to safety issues in drug development and beyond
    Joanna F Haas
    Pharmacovigilance, Genzyme Corporation, Cambridge, Massachusetts 02142, USA
    Drug Saf 27:555-67. 2004
  2. ncbi Commentary: Epidemiology and the pharmaceutical industry: an inside perspective
    Joanna Haas
    Pharmacovigilance, Genzyme Corporation, For the Pharmaceutical Research and Manufacturers of America Pharmocovigilance and Epidemiology Group, 675 W Kendall Street, Cambridge MA 02142, USA
    Int J Epidemiol 37:53-5; discussion 65-8. 2008
  3. ncbi An audience with...Joanna F. Haas
    Joanna F Haas
    Pharmacovigilance, Genzyme Corporation
    Nat Rev Drug Discov 4:806. 2005

Detail Information

Publications3

  1. ncbi A problem-oriented approach to safety issues in drug development and beyond
    Joanna F Haas
    Pharmacovigilance, Genzyme Corporation, Cambridge, Massachusetts 02142, USA
    Drug Saf 27:555-67. 2004
    ..Overall, the problem-oriented approach, supported by a SEP, contributes to realistic expectations and sustained credibility when dealing with safety issues...
  2. ncbi Commentary: Epidemiology and the pharmaceutical industry: an inside perspective
    Joanna Haas
    Pharmacovigilance, Genzyme Corporation, For the Pharmaceutical Research and Manufacturers of America Pharmocovigilance and Epidemiology Group, 675 W Kendall Street, Cambridge MA 02142, USA
    Int J Epidemiol 37:53-5; discussion 65-8. 2008
  3. ncbi An audience with...Joanna F. Haas
    Joanna F Haas
    Pharmacovigilance, Genzyme Corporation
    Nat Rev Drug Discov 4:806. 2005